Hurthle cell carcinoma
For patient information click here
| Hurthle cell carcinoma | |
| ICD-10 | C73.9 |
|---|---|
| ICD-O: | 8290/0 |
| DiseasesDB | 31956 |
| MeSH | D018249 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
A Hürthle cell (also known as Askanazy cell) is an oncocytic cell in the thyroid that is often associated with Hashimoto's thyroiditis as well as follicular thyroid cancer. Hürthle cells are characterized as enlarged epithelial cells with abundant eosinophilic granular cytoplasm as a result of altered mitochondria.[1] They generally stain pink and are prominently found in histological sections of thyroid glands affected with Hashimoto's.
A Hürthle cell adenoma is a well-differentiated type of follicular thyroid adenoma (benign tumor) that, in rare cases, has the potential to metastasize and become malignant (Hürthle cell carcinoma).
See also
References
- ↑ Aytug, Serhat (June 13, 2006). "Hurthle Cell Carcinoma". eMedicine. Check date values in:
|date=(help)